NEW YORK — Canadian health data company Avricore Health said on Tuesday that it has signed a letter of intent to work with Avrok Laboratories to offer rapid SARS-CoV-2 antigen testing for international travelers.
Avrok, which operates a CLIA-certified lab in California, will oversee the testing of travelers in Canada, the US, Mexico, and the Caribbean, for example at resorts and through airlines. The test results will then be reported directly via Avricore's HealthTab point-of-care screening and test result management platform.